T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Kelly Services Class A
KELYA
$554M
| $173K | ﹤0.01% |
12,383
+2,298
| +23% | +$38.8K |
|
2727
Humacyte
HUMA
$154M
| $172K | ﹤0.01% |
33,870
+5,801
| +21% | +$28.7K |
|
2728
Zevra Therapeutics
ZVRA
$667M
| $172K | ﹤0.01% |
20,565
+6,966
| +51% | +$59.5K |
|
2729
Lincoln Educational Services
LINC
$978M
| $171K | ﹤0.01% |
+10,775
| New | +$157K |
|
|
SEMR
2730
DELISTED
Semrush
SEMR
| $170K | ﹤0.01% |
14,242
+2,471
| +21% | +$33.2K |
|
2731
Columbia Financial
CLBK
$1.23B
| $168K | ﹤0.01% |
+10,564
| New | +$182K |
|
|
PPTA
2732
Perpetua Resources
PPTA
$3.1B
| $168K | ﹤0.01% |
15,722
+3,067
| +24% | +$31.5K |
|
2733
Celcuity
CELC
$4.27B
| $167K | ﹤0.01% |
+12,721
| New | +$179K |
|
|
NXDR
2734
Nextdoor Holdings
NXDR
$1.01B
| $164K | ﹤0.01% |
69,015
+13,365
| +24% | +$33.1K |
|
|
VERV
2735
DELISTED
Verve Therapeutics
VERV
| $164K | ﹤0.01% |
28,998
-11,116
| -28% | -$62.7K |
|
2736
Telos
TLS
$339M
| $163K | ﹤0.01% |
47,588
+2,546
| +6% | +$9.11K |
|
|
URG
2737
Ur-Energy
URG
$537M
| $163K | ﹤0.01% |
141,334
+27,596
| +24% | +$34K |
|
|
PKST
2738
DELISTED
Peakstone Realty Trust
PKST
| $162K | ﹤0.01% |
14,591
+2,862
| +24% | +$37.3K |
|
2739
Aldeyra Therapeutics
ALDX
$92.3M
| $161K | ﹤0.01% |
32,105
-23,517
| -42% | -$121K |
|
|
OPTU
2740
Optimum Communications Inc
OPTU
$232M
| $161K | ﹤0.01% |
66,400
| – | – |
|
2741
Bioventus
BVS
$1.17B
| $160K | ﹤0.01% |
15,194
+3,153
| +26% | +$37.3K |
|
2742
Pangaea Logistics
PANL
$493M
| $160K | ﹤0.01% |
29,760
+1,762
| +6% | +$10.6K |
|
|
ATXS
2743
DELISTED
Astria Therapeutics
ATXS
| $159K | ﹤0.01% |
17,762
+2,878
| +19% | +$30.6K |
|
2744
Nano X Imaging
NNOX
$75M
| $159K | ﹤0.01% |
21,990
+4,658
| +27% | +$29.8K |
|
2745
Vipshop
VIPS
$6.78B
| $159K | ﹤0.01% |
11,800
| – | – |
|
2746
Teekay
TK
$1.06B
| $158K | ﹤0.01% |
22,673
+4,096
| +22% | +$31.6K |
|
|
HONE
2747
DELISTED
HarborOne Bancorp
HONE
| $157K | ﹤0.01% |
13,233
+500
| +4% | +$6.34K |
|
|
GPGI
2748
GPGI Inc
GPGI
$3.84B
| $156K | ﹤0.01% |
+12,221
| New | +$155K |
|
2749
Talkspace
TALK
$871M
| $156K | ﹤0.01% |
50,177
+10,849
| +28% | +$33K |
|
2750
Olema Pharmaceuticals
OLMA
$913M
| $153K | ﹤0.01% |
26,112
-5,346
| -17% | -$53.4K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.